Depomed Provides Update on Phase III Trial of Ciprofloxacin GR at Thomas Weisel Partners Healthcare Conference.
Business Wire › September 04, 2003
Linked as:
Extract
Depomed Provides Update on Phase III Trial of Ciprofloxacin GR at Thomas Weisel Partners Healthcare Conference.
Business Editors/Health/Medical Writers
MENLO PARK, Calif.--(BUSINESS WIRE)--Sept. 4, 2003 Ongoing Results from Phase III Trial Indicate Once Daily Ciprofloxacin GR(TM) is as Effective as CIPRO(R) in Treatment of Uncomplicated Urinary Tract Infections Depomed, Inc. (AMEX: DMI) today ann...See the full content of this document
Sponsored links
